Acciones Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Acciones
IL0010810096
Farmacéuticos
Ventas 2022 | 292 M 77,65 M 29,24 mil M 72,5 M | Ventas 2023 | 322 M 85,43 M 32,17 mil M 79,75 M | Capitalización | 169 M 44,8 M 16,87 mil M 41,83 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -2 M -531 mil -200 M -496 mil | Resultado Neto 2023 | -6 M -1,59 M -600 M -1,49 M | VE / Ventas 2022 | 1,1 x |
Deuda neta 2022 | 145 M 38,62 M 14,54 mil M 36,05 M | Deuda neta 2023 | 166 M 44,2 M 16,64 mil M 41,27 M | VE / Ventas 2023 | 1,04 x |
P/E ratio 2022 |
-85,5
x | P/E ratio 2023 |
-24,2
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 17,36 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,15 % | 75,76 mil M | |
-2,46 % | 23,95 mil M | |
+14,23 % | 8703,63 M | |
+1,47 % | 8292,96 M | |
-32,92 % | 6697,69 M | |
+18,62 % | 5382,7 M | |
+1,10 % | 4078,74 M | |
-9,24 % | 3791,89 M | |
-10,20 % | 3298,39 M |